Becton, Dickinson and Co. plans to invest more than $110 million to expand a prefilled flush syringe manufacturing facility in Nebraska. According to BD, the plan aims to better meet growing demand ...
Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used ...
Amid constant drug shortages exacerbated by weak links in the supply chain, medical glass maker Schott Pharma is looking to fill the cracks with a new $371 million North Carolina facility. Along with ...
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Expansion Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary 14.06.2024 / ...
FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its ...
Ottawa, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The global Europe glass prefilled syringes and glass vials packaging equipment market, which stood at USD 283.30 billion in 2025, is projected to grow further ...
SCHOTT Pharma will invest $371 million to build the first U.S. facility to manufacture prefillable polymer syringes in Wilson, North Carolina. The syringes are required to meet the need for deep-cold ...
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results